Showing 1 - 8 results of 8 for search 'Inken Flörkemeier', query time: 0.03s
Refine Results
-
1
The Aza-Analogous Benzo[<i>c</i>]phenanthridine P8-D6 Acts as a Dual Topoisomerase I and II Poison, thus Exhibiting Potent Genotoxic Properties by Georg Aichinger, Falk-Bach Lichtenberger, Tamara N. Steinhauer, Inken Flörkemeier, Giorgia Del Favero, Bernd Clement, Doris Marko
Published 2020-03-01
Article -
2
Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer by Inken Flörkemeier, Julia S. Hillmann, Jörg P. Weimer, Jonas Hildebrandt, Nina Hedemann, Christoph Rogmans, Astrid Dempfle, Norbert Arnold, Bernd Clement, Dirk O. Bauerschlag
Published 2022-09-01
Article -
3
High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer by Inken Flörkemeier, Tamara N. Steinhauer, Nina Hedemann, Jörg Paul Weimer, Christoph Rogmans, Marion T. van Mackelenbergh, Nicolai Maass, Bernd Clement, Dirk O. Bauerschlag
Published 2021-12-01
Article -
4
Assessing the Phenotype of a Homologous Recombination Deficiency Using High Resolution Array-Based Comparative Genome Hybridization in Ovarian Cancer by Svetlana Magadeeva, Xueqian Qian, Nadine Korff, Inken Flörkemeier, Nina Hedemann, Christoph Rogmans, Michael Forster, Norbert Arnold, Nicolai Maass, Dirk O. Bauerschlag, Jörg P. Weimer
Published 2023-12-01
Article -
5
ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer by Christoph Rogmans, Jan Dominik Kuhlmann, Gerrit Hugendieck, Theresa Link, Norbert Arnold, Jörg Paul Weimer, Inken Flörkemeier, Anna-Christina Rambow, Wolfgang Lieb, Nicolai Maass, Dirk O. Bauerschlag, Nina Hedemann
Published 2021-11-01
Article -
6
Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages by Christoph Rogmans, Julia Feuerborn, Leonie Treeck, Nils Tribian, Inken Flörkemeier, Norbert Arnold, Jörg Paul Weimer, Nicolai Maass, Peer Jansen, Wolfgang Lieb, Astrid Dempfle, Dirk O. Bauerschlag, Nina Hedemann
Published 2022-11-01
Article -
7
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids by Nina Hedemann, Andreas Herz, Jan Hendrik Schiepanski, Jan Dittrich, Susanne Sebens, Astrid Dempfle, Julia Feuerborn, Christoph Rogmans, Nils Tribian, Inken Flörkemeier, Jörg Weimer, Sandra Krüger, Nicolai Maass, Dirk O. Bauerschlag
Published 2021-04-01
Article -
8
Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer by Gerrit Hugendieck, Marcus Lettau, Svenja Andreas, Sabrina Neumann, Natalie Reinhardt, Philipp Arnold, Franziska Theilig, Lorenz Bastian, Christoph Rogmans, Jörg P. Weimer, Inken Flörkemeier, Daniela Wesch, Norbert Arnold, Nicolai Maass, Ottmar Janssen, Dirk Bauerschlag, Nina Hedemann
Published 2023-07-01
Article